Lim HL - Search Results

1

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

Soo RA, Lim HL, Wang LZ, Lee HS, Millward MJ, Tok LT, Lee SC, Lehnert M, Goh BC. Soo RA, et al. Among authors: lim hl. Cancer Chemother Pharmacol. 2003 Aug;52(2):153-8. doi: 10.1007/s00280-003-0637-5. Epub 2003 May 16. Cancer Chemother Pharmacol. 2003. PMID: 12750842 Clinical Trial.

2

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer.

Goh BC, Lehnert M, Lim HL, Ng AW, Chan CC, Kong HL, Lee SC, Wee J, Chua ET, Wong JE. Goh BC, et al. Among authors: lim hl. Acta Oncol. 2000;39(2):225-9. doi: 10.1080/028418600430824. Acta Oncol. 2000. PMID: 10859016 Clinical Trial.

3

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer.

Soo RA, Wang LZ, Tham LS, Yong WP, Boyer M, Lim HL, Lee HS, Millward M, Liang S, Beale P, Lee SC, Goh BC. Soo RA, et al. Among authors: lim hl. Ann Oncol. 2006 Jul;17(7):1128-33. doi: 10.1093/annonc/mdl084. Epub 2006 May 2. Ann Oncol. 2006. PMID: 16670205 Free article. Clinical Trial.

4

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Tsui DWY, Murtaza M, Wong ASC, Rueda OM, Smith CG, Chandrananda D, Soo RA, Lim HL, Goh BC, Caldas C, Forshew T, Gale D, Liu W, Morris J, Marass F, Eisen T, Chin TM, Rosenfeld N. Tsui DWY, et al. Among authors: lim hl. EMBO Mol Med. 2018 Jun;10(6):e7945. doi: 10.15252/emmm.201707945. EMBO Mol Med. 2018. PMID: 29848757 Free PMC article.

5

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma.

Wong AS, Soo RA, Lu JJ, Loh KS, Tan KS, Hsieh WS, Shakespeare TP, Chua ET, Lim HL, Goh BC. Wong AS, et al. Among authors: lim hl. Ann Oncol. 2006 Jul;17(7):1152-7. doi: 10.1093/annonc/mdl090. Epub 2006 May 9. Ann Oncol. 2006. PMID: 16684789 Free article. Clinical Trial.

6

Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities.

Aw DC, Tan EH, Chin TM, Lim HL, Lee HY, Soo RA. Aw DC, et al. Among authors: lim hl. Asia Pac J Clin Oncol. 2018 Feb;14(1):23-31. doi: 10.1111/ajco.12687. Epub 2017 May 2. Asia Pac J Clin Oncol. 2018. PMID: 28464435 Review.

7

Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer.

Chong CF, Khoo KL, Lim TK, Chang AY, Lim HL, Lee CN, Wong PS. Chong CF, et al. Among authors: lim hl, lim tk. Singapore Med J. 2007 Jul;48(7):620-4. Singapore Med J. 2007. PMID: 17609822 Free article.

8

Cancer: To tell or not to tell?

Tan TK, Teo FC, Wong K, Lim HL. Tan TK, et al. Among authors: lim hl. Singapore Med J. 1993 Jun;34(3):202-3. Singapore Med J. 1993. PMID: 8266172

9

Treatment of acute promyelocytic leukaemia in first relapse with all-trans retinoic acid.

Wong K, Lim HL, Teo CP, Tan YO, Kueh YK. Wong K, et al. Among authors: lim hl. Ann Acad Med Singap. 1995 Jan;24(1):177-9. Ann Acad Med Singap. 1995. PMID: 7605089

10

Multiple myeloma: the National University Hospital (NUH) experience.

Lim HL, Teo CP, Wong K, Kuperan P, Suri R, Tan YO, Kueh YK. Lim HL, et al. Singapore Med J. 1994 Aug;35(4):371-3. Singapore Med J. 1994. PMID: 7899894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters